SCHEMBL7481

SCHEMBL7481

Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1CCCC(O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 5/20 0.55
LPAR3 Q9UBY5 2/20 0.46
LPAR2 Q9HBW0 1/20 0.46
ABCC4 O15439 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
PTGS1 P23219 1/20 0.43
HTT P42858 1/20 0.43
RORC P51449 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
S1PR1 P21453 3/20 0.39
S1PR3 Q99500 2/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
NR1H4 Q96RI1 2/20 0.37
PPARD Q03181 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6889 0.90 FFAR1 (0.46) LPAR1LPAR3LPAR2ALDH1A1L3MBTL1
SCHEMBL6024 0.89 LPAR1 (0.46) LPAR1LPAR3LPAR2GAATSHR
SCHEMBL6801 0.84 SMN1; SMN2 (0.46) LPAR1LPAR3LMNAGAAALDH1A1
SCHEMBL7242 0.84 LIPG (0.44) LPAR1S1PR1S1PR3NR1H4PPARD
SCHEMBL6779 0.84 LPAR1 (0.42) LPAR1LPAR3ALDH1A1L3MBTL1S1PR1
SCHEMBL7190 0.84 LPAR1 (0.40) LPAR1LPAR3LPAR2ABCC4ALDH1A1
SCHEMBL7250 0.83 PPARG (0.46) LPAR1LPAR3PTGDR2ALDH1A1L3MBTL1
SCHEMBL7480 0.83 LPAR1 (0.50) LPAR1LPAR3LPAR2ABCC4LMNA
SCHEMBL6861 0.82 LPAR1 (0.42) LPAR1LPAR3ABCC4TSHRALDH1A1
SCHEMBL6549 0.81 FFAR4 (0.45) LPAR1LPAR3ALDH1A1L3MBTL1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-B1 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS INC (US) 2017-03-08 EP claimed
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP claimed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO claimed
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed